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LETTERS TO THE EDITOR
Defining Stent
Thrombosis: Whose Definition to Use?
In their single-center registry, Orford et al. (1) considered stent
thrombosis to have occurred when death was sudden and unex-
plained (11 patients), when a myocardial infarction (MI) occurred
in the territory of the treated vessel (9 patients), or, in one case, on
the basis of diagnostic angiography alone. Two patients did not
fulfill these criteria, but were inexplicably included in the stent
thrombosis group. The investigators conclude that, when stent
thrombosis occurs, the majority of patients either die or have a
nonfatal MI; however, this is only a consequence of the definition
of stent thrombosis used by the investigators.
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REPLY
We appreciate the comments and acknowledge the concerns of Dr.
Martı´nez-Selle´s regarding the diagnosis of stent thrombosis in our
analysis of the Mayo Clinic registry (1). It may be quite reasonably
argued that a definitive diagnosis of stent thrombosis requires
angiographic confirmation, perhaps with even angioscopic evi-
dence of thrombus, or autopsy (2). If this had been feasible, it is
likely that a number of cases that we considered to represent stent
thrombosis would not have been attributable to thrombotic occlu-
sion within the stent. Similarly, although stent thrombosis is a
highly morbid event that results in Q-wave infarction and death in
the majority of cases, it is also possible that some cases of stent
thrombosis might have occurred subclinically and been missed in
our analysis.
However, our interest in this pathologic entity arises primarily
from the clinical sequelae of this complication. Therefore, we
considered all patients to have had stent thrombosis when it was
confirmed angiographically, when a myocardial infarction (MI)
(ST- or non–ST segment elevation) occurred in the territory of the
treated vessel and stent thrombosis could not be definitively
excluded, or when death was sudden and unexplained, a definition
that has been widely used by others (3–9). Therefore, although Dr.
Martı´nez-Selle´s is correct that we may have both included some
cases not due to stent thrombosis and missed some that were, such
a definition using “hard” end points is both practical and allows for
sensible comparisons of preventative and therapeutic strategies,
and we believed it would be most suitable for this study of
frequency and correlates of this complication of percutaneous
coronary intervention.
Finally, we must thank Dr. Martı´nez-Selle´s for allowing us to
clarify the outcomes associated with stent thrombosis in our
population. There were in fact three cases of stent thrombosis
without MI or death that were diagnosed by coronary angiogra-
phy, not one. We apologize for this error.
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Calculating the Absolute
Value of the Mean Left Atrial
Maximal and Minimal Volume
We enjoyed the study by Thomas et al. published in the Journal
(1); however, we have some concern regarding the absolute value of
the calculated mean left atrial maximal and minimal volume. In
patients without mitral regurgitation, the reservoir volume (left
atrial total emptying volume) of the left atrium represents the
amount of blood coming from the pulmonary vein during ventric-
ular systole. In the case of the younger group of the present study,
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